When looking for a reliable legal partner to oversee corporate governance, foresee potential complications and address challenges, clients require a firm with agility and precision. Dentons is that reliable partner. Our US Corporate Governance practice assists private, public and not-for-profit companies, advising boards, committees, management and leadership on obligations and legal protection.

We address the most sensitive internal corporate governance issues with utmost care, such as working with auditors and financial advisors, conducting internal investigations, advising on executive and director compensation techniques and handling disclosure in a manner that is sensitive to the concerns of investors, the volatility of markets and continued successful business operations. Dentons can advise on best practices that mitigate risk of corporate fraud by implementing clear and consistent polices.

Externally, Dentons tackles your most pressing and complex challenges, including negotiating with securities regulators and other enforcement agencies and strategizing takeover preparedness and response. Our team responds to shareholder activism in a manner that respects all constituencies. When civil litigation arises, we safeguard client interests throughout the process . When confronting the maze of US compliance issues—including SEC, stock exchange and Sarbanes-Oxley regulations—we steer clients around every obstacle.

We are prepared to counsel you in any range of situations involving:

• Committee representation
• Communications policy
• Compliance
• Disclosure
• Fiduciary duties
• Fraud
• Investor relations
• Operational, political, communications and market factors
• Securities regulation
• Shareholder activism
• Strategic planning issues

Insights

SEC Adopts New SPAC and de-SPAC Rules

January 30, 2024

United States: On January 24, 2024, the Securities and Exchange Commission adopted new rules to enhance disclosure and provide additional investor protections in IPOs by special purpose acquisition companies and in subsequent business combination transactions between SPACs and target operating companies.

Delaware Court of Chancery Provides Roadmap for Evaluating Advance Notice Bylaws

January 19, 2024

United States: In a recent decision, the Delaware Court of Chancery upheld the rejection of a proposed slate of director nominees by the incumbent board of AIM ImmunoTech, Inc. (“AIM” or the “Company”) for AIM’s 2023 Annual Meeting of Stockholders.

Ukraine Recovery Week, London 19-23 June 2023 – Key Takeaways

June 27, 2023

Ukraine: Last week Dentons lawyers were privileged to participate in the Ukraine Recovery Conference 2023 (URC23), which was hosted in London on June 21–22 and organized by the governments of the United Kingdom and Ukraine.

View all insights for Corporate Governance in the United States

News and Events

Recent Press Releases

Dentons shortlisted in 26 categories in the Women in Business Law Americas Awards 2022

April 26, 2022

Dentons has been shortlisted in a total of 26 categories by Euromoney in the Women in Business Law Americas Awards 2022.